Comment:

RC Stenner

Thalassemia major: the iron irony
Haematologica 2005 90: 1297A.  

DA Scheinberg

Immune surveillance of leukemia?
Haematologica 2005 90: 1297B.  

M Yasukawa

Synthetic peptide analogs derived from bcr/abl fusion proteins induce heteroclitic human T cell responses
Haematologica 2005 90: 1297B.  

R Mesa

Pegylated interferon for the treatment of high-risk essential thrombocythemia
Haematologica 2005 90: 1298B.  

MG Della Porta, L Malcovati

Outcome after allogeneic bone marrow transplantation in cytogenetic high-risk myelodysplastic syndromes and acute myeloid leukemia
Haematologica 2005 90: 1298C.  

R Bassan

Evolving strategies for the management of high-risk adult acute lymphoblastic leukemia
Haematologica 2005 90: 1299.  

A Ferrajoli

Bendamustine in relapsed or refractory chronic lymphocytic leukemia
Haematologica 2005 90: 1300A.  

AC Rawstron

Minimal residual disease detection in myeloma: no more molecular remissions?
Haematologica 2005 90: 1300B.  

M Bornhauser, C Thiede

Chimerism analysis after allogeneic stem cell transplantation
Haematologica 2005 90: 1301A.  

DA Jacobsohn

Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary disease following allografting
Haematologica 2005 90: 1301B.  

M Mohty

CD25 expression on donor CD8+ T cells and graft-versus-host disease
Haematologica 2005 90: 1302A.  

A Busca

Hepatic veno-occlusive disease following stem cell transplantation: younger patients are not sheltered from this complication
Haematologica 2005 90: 1302B.  

JE Barker

T time
Haematologica 2005 90: 1303A.  

R Maccario

Gene transfer of HA-1 specificity
Haematologica 2005 90: 1303B.  

D Loukopoulos

Combined therapy with deferiprone and desferrioxamine in thalassemia major
Haematologica 2005 90: 1304-1305. [PDF]  

SV Rajkumar, A Dispenzieri

Evaluation and monitoring of response to therapy in multiple myeloma
Haematologica 2005 90: 1305-1308. [PDF]  

Journal Article:

R Origa, P Bina, A Agus, G Crobu, E Defraia, C Dessi, G Leoni, PP Muroni, R Galanello

Combined therapy with deferiprone and desferrioxamine in thalassemia major
Haematologica 2005 90: 1309-1314. [Abstract] [PDF]  

Comparative Study:

NM Butt, JM Rojas, L Wang, SE Christmas, HM Abu-Eisha, RE Clark

Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects
Haematologica 2005 90: 1315-1323. [Abstract] [PDF]  

J Pinilla-Ibarz, T Korontsvit, V Zakhaleva, W Roberts, DA Scheinberg

Synthetic peptide analogs derived from bcr/abl fusion proteins and the induction of heteroclitic human T-cell responses
Haematologica 2005 90: 1324-1332. [Abstract] [PDF]  

HM van der Straaten, A van Biezen, R Brand, AV Schattenberg, RM Egeler, RM Barge, JJ Cornelissen, HC Schouten, GJ Ossenkoppele, LF Verdonck, Netherlands Stem Cell Transplant Registry "TYPHON"

Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities
Haematologica 2005 90: 1339-1345. [Abstract] [PDF]  

JM Ribera, A Oriol, C Bethencourt, R Parody, JM Hernandez-Rivas, MJ Moreno, E del Potro, M Torm, C Rivas, J Besalduch, MA Sanz, JJ Ortega, PETHEMA Group, Spain

Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial
Haematologica 2005 90: 1346-1356. [Abstract] [PDF]  

ME Sarasquete, R Garcia-Sanz, D Gonzalez, J Martinez, G Mateo, P Martinez, JM Ribera, JM Hernandez, JJ Lahuerta, A Orfao, M Gonzalez, JF San Miguel

Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry
Haematologica 2005 90: 1365-1372. [Abstract] [PDF]  

I Buno, P Nava, A Simon, M Gonzalez-Rivera, JL Jimenez, P Balsalobre, D Serrano, R Carrion, A Gomez-Pineda, JL Diez-Martin

A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation
Haematologica 2005 90: 1373-1379. [Abstract] [PDF]  

JH Lee, SJ Choi, JH Lee, M Seol, YS Lee, SG Ryu, CJ Park, HS Chi, MS Lee, S Yun, JS Lee, KH Lee

Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia
Haematologica 2005 90: 1380-1388. [Abstract] [PDF]  

T Mutis, T Aarts-Riemens, LF Verdonck

The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions
Haematologica 2005 90: 1389-1395. [Abstract] [PDF]  

S Cesaro, M Pillon, E Talenti, T Toffolutti, E Calore, G Tridello, L Strugo, R Destro, MV Gazzola, S Varotto, G Errigo, M Carli, L Zanesco, C Messina

A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation
Haematologica 2005 90: 1396-1404. [Abstract] [PDF]  

MG Seidel, G Fritsch, S Matthes-Martin, A Lawitschka, T Lion, U Potschger, A Rosenmayr, G Fischer, H Gadner, C Peters

In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation
Haematologica 2005 90: 1405-1414. [Abstract] [PDF]  

B Mommaas, AG van Halteren, J Pool, L van der Veken, B Wieles, MH Heemskerk, E Goulmy

Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer
Haematologica 2005 90: 1415-1421. [Abstract] [PDF]  

M van Agthoven, MH Kramer, P Sonneveld, KG van der Hem, PC Huijgens, PW Wijermans, HC Kluin-Nelemans, MR Schaafsma, DH Biesma, V Mattijssen, CA Uyl-de Groot, A Hagenbeek

Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma
Haematologica 2005 90: 1422-1432. [Abstract] [PDF]  

S Hipp, I Ringshausen, M Oelsner, C Bogner, C Peschel, T Decker

Inhibition of the mammalian target of rapamycin and the induction of cell cycle arrest in mantle cell lymphoma cells
Haematologica 2005 90: 1433-1434. [Abstract] [PDF]  

NC Osuji, I Del Giudice, E Matutes, AC Wotherspoon, C Dearden, D Catovsky

The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53
Haematologica 2005 90: 1435-1436. [Abstract] [PDF]  

CG Schaar, HJ Vermeer, PW Wijermans, W Huisman, S le Cessie, HC Kluin-Nelemans

Serum syndecan-1 in patients with newly diagnosed monoclonal proteinemia
Haematologica 2005 90: 1437-1438. [Abstract] [PDF]  

Clinical Trial, Phase II:

C Langer, E Lengfelder, J Thiele, HM Kvasnicka, HL Pahl, H Beneke, S Schauer, H Gisslinger, M Griesshammer

Pegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II study
Haematologica 2005 90: 1333-1338. [Abstract] [PDF]  

Clinical Trial, Phase I:

MA Bergmann, ME Goebeler, M Herold, B Emmerich, M Wilhelm, C Ruelfs, L Boening, MJ Hallek, German CLL Study Group

Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group
Haematologica 2005 90: 1357-1364. [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.